Literature DB >> 21331683

[Ophthalmologic diagnostic procedures and imaging of retinal vein occlusions].

A Mirshahi1, K Lorenz, C Kramann, B Stoffelns, L-O Hattenbach.   

Abstract

Retinal vein occlusions are a common vascular disease of the eye. Ophthalmological diagnostic procedures and imaging are important for the prognosis of the disease, as are the systemic work-up and therapy. Besides routine ophthalmic tests (visual acuity, slit lamp examination, funduscopy) a work-up for glaucoma such as intraocular pressure, visual field or 24 h IOP profile is useful as a diagnostic procedure. Furthermore, new diagnostic and imaging tests such as central corneal thickness and optic nerve head imaging by Heidelberg retina tomography or optical coherence tomography (OCT) should be considered for glaucoma evaluation. Optical coherence tomography also plays a major role in treatment monitoring of macular edema secondary to retinal vein occlusions. Fluorescein angiography is well established and can provide information with regard to size and extent of the occlusion, degree of ischemia, areas of non-perfusion and neovascularization, as well as macular edema.

Entities:  

Mesh:

Year:  2011        PMID: 21331683     DOI: 10.1007/s00347-010-2290-9

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  38 in total

Review 1.  Color Doppler imaging of orbital vessels: personal experience and literature review.

Authors:  François Tranquart; Olivier Bergès; Patricia Koskas; Sophie Arsene; Christian Rossazza; Pierre-Jean Pisella; Léandre Pourcelot
Journal:  J Clin Ultrasound       Date:  2003-06       Impact factor: 0.910

Review 2.  Color Doppler ultrasonography of the eye and orbit.

Authors:  W E Lieb
Journal:  Curr Opin Ophthalmol       Date:  1993-06       Impact factor: 3.761

Review 3.  Natural history of central retinal vein occlusion: an evidence-based systematic review.

Authors:  Rachel L McIntosh; Sophie L Rogers; Lyndell Lim; Ning Cheung; Jie Jin Wang; Paul Mitchell; Jonathan W Kowalski; Hiep P Nguyen; Tien Yin Wong
Journal:  Ophthalmology       Date:  2010-06       Impact factor: 12.079

4.  Relative afferent pupillary defect in central retinal vein occlusion.

Authors:  G E Servais; H S Thompson; S S Hayreh
Journal:  Ophthalmology       Date:  1986-03       Impact factor: 12.079

5.  OCT patterns of macular edema and response to bevacizumab therapy in retinal vein occlusion.

Authors:  Alexandra Eva Hoeh; Mira Ruppenstein; Thomas Ach; Stefan Dithmar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-07-02       Impact factor: 3.117

6.  Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.

Authors:  David M Brown; Peter A Campochiaro; Rishi P Singh; Zhengrong Li; Sarah Gray; Namrata Saroj; Amy Chen Rundle; Roman G Rubio; Wendy Yee Murahashi
Journal:  Ophthalmology       Date:  2010-04-09       Impact factor: 12.079

7.  The natural course of temporal retinal branch vein occlusion.

Authors:  F A Gutman; H Zegarra
Journal:  Trans Am Acad Ophthalmol Otolaryngol       Date:  1974 Mar-Apr

Review 8.  Prevalent misconceptions about acute retinal vascular occlusive disorders.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2005-07       Impact factor: 21.198

9.  Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.

Authors:  John J Wroblewski; John A Wells; Anthony P Adamis; Ronald R Buggage; Emmett T Cunningham; Mauro Goldbaum; David R Guyer; Barrett Katz; Michael M Altaweel
Journal:  Arch Ophthalmol       Date:  2009-04

10.  The natural course of central retinal vein occlusion.

Authors:  P M Quinlan; M J Elman; A K Bhatt; P Mardesich; C Enger
Journal:  Am J Ophthalmol       Date:  1990-08-15       Impact factor: 5.258

View more
  2 in total

1.  [Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema].

Authors:  M Rehak; E Spies; M Scholz; P Wiedemann
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

2.  [Reliability and safety of intravitreal Ozurdex injections. The ZERO study].

Authors:  K Schmitz; M Maier; C R Clemens; F Höhn; J Wachtlin; F Lehmann; T Bertelmann; K Rüdiger; M Horn; A Bezatis; G Spital; C H Meyer
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.